Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTI.L Regulatory News (CTI)

  • There is currently no data for CTI

Share Placement

20 Apr 2006 16:14

Cathay International Holdings Ld20 April 2006 Cathay International Holdings Limited 20 April 2006 CATHAY INTERNATIONAL HOLDINGS LIMITED (the "Company") Share Placement The Company announces that it has raised £1,500,000 by way of a privateplacement of 15,000,000 new common shares of US$0.05 each (the "New CommonShares") at an issue price of 10 pence per share (the "Placing"). The issueprice was at a discount of approximately 9.38% to the average closing price ofthe Company's common shares for 90 consecutive trading days immediately prior todate of this announcement. The principal purpose of the Placing is to ensure that at least 25% of theCompany's listed securities are in public hands, as required by the listingrules of the UK Listing Authority (the "UKLA") and to introduce some newinvestors to the Company. It is intended that the funds raised will be used forgeneral working capital. The Company has the authority to issue the New Common Shares under the Placingpursuant to resolutions passed by shareholders at the special general meeting ofthe Company held on 16 August 2005. The New Common Shares represent 5.75% of the existing issued share capital ofthe Company and will represent 5.44% of the issued share capital of the Companyas enlarged as a result of the Placing. The New Common Shares will rank pari passu in all respect with all existingcommon shares of the Company. Application will be made to the UKLA for the NewCommon Shares to be admitted to the Official List and application will be madeto the London Stock Exchange for the New Common Shares to be admitted to tradingon its market for listed securities (together "Admission"). The issue of the NewCommon Shares is subject to Admission becoming effective on or before 31 May2006. It is expected that Admission will become effective and that dealings willcommence in the New Common Shares at 8.00 a.m. on 26 April 2006. Following the completion of the Placing, the interests of each director of theCompany (including any person connected to him) and the persons known to theCompany to be interested in three per cent. or more of the Company's capital areexpected to be as follows: Directors' interests in the Company New Common Shares Shareholding following % of enlarged subscribed in the Placing share capital the Placing A Shares Common Shares James Buchanan - 119,999 1,585,009 0.62 Wu Zhen Tao - 8,249,276 172,376,874 65.48 Stephen Hunt - - - - Patrick Sung - - - - John Cosson - 726 8,629 0.00 Note: Mr. Wu Zhen Tao's interest arises as a result of his indirect beneficialinterest in Cathay International Enterprises Limited. Substantial interests New Common Shares Shareholding following % of enlarged subscribed in the Placing share capital the Placing A Shares Common SharesCathay InternationalEnterprises Limited(through its 100% owned subsidiaries) - 8,249,276 172,376,874 65.48 Simon Phillips 3,000,000 92,075 16,827,321 6.13 New CapitalInvestment (Hong Kong) Limited - 864,513 9,121,679 3.62 Note: Cathay International Enterprises Limited is indirectly owned by a trustthe beneficiaries of which are Mr. Wu Zhen Tao and members of his family. Following the completion of the Placing, approximately 27.77% of the Company'slisted securities will be in public hands, for the purposes of the Listing Rulesof the UKLA. Enquiries: Stephen HuntDirector, Cathay International Holdings LimitedTelephone: + 852 2828 9289 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Apr 20118:59 amRNSGrant of Share Options
24th Mar 20119:02 amRNSAnnual Report and Accounts
18th Mar 20119:09 amRNSGrant of share options
16th Mar 20117:00 amRNSAnnual Results for the Year Ended 31 December 2010
10th Mar 20119:55 amRNSNotice of Results
9th Mar 20117:00 amRNSAppointment of Adviser
29th Nov 20107:30 amRNSZhejiang Starry Pharmaceutical Co., Ltd.
19th Nov 20107:27 amRNSInterim Management Statement
16th Nov 20107:00 amRNSZhejiang Starry Pharmaceutical Co., Ltd.
26th Aug 20105:04 pmRNSINTERIM RESULTS 2010
4th Jun 20107:00 amRNSResults of AGM and change of Director's role
1st Jun 20107:06 amRNSLansen Pharmaceutical Holdings - Update
19th May 20103:32 pmRNSInterim Management Statement
12th May 201010:37 amRNSAnnual Information Update
6th May 20107:32 amRNSLansen Pharmaceutical Holdings Company Limited
27th Apr 20104:25 pmRNSLansen Pharmaceutical Holdings Company Limited
27th Apr 20104:22 pmRNSPRELIMINARY RESULTS
19th Apr 20101:41 pmRNSResult of Special General Meeting
16th Apr 201012:38 pmRNSSpecial General Meeting on 19 April 2010
6th Apr 20105:18 pmRNSPublication of Circular
1st Apr 20101:09 pmRNSLansen Pharmaceutical Holdings Company
23rd Mar 20109:00 amRNSAdditional Listing
26th Feb 20109:07 amRNSAdditional Listing
12th Feb 20106:06 pmRNSUpdate on further investment in Xian Haotian Group
26th Jan 20105:18 pmRNSAnnual Information Update
21st Jan 20105:56 pmRNSAppointment of Directors and Issue of Equity
7th Dec 20099:11 amRNSTotal Voting Rights and Share Capital
4th Dec 200911:16 amRNSResult of SGM
4th Dec 20097:06 amRNSResult of Placing Open Offer
19th Nov 200911:03 amRNSInterim Management Statement
18th Nov 20095:24 pmRNSPublication of Prospectus
18th Nov 20097:00 amRNSPlacing and Open Offer
26th Aug 20092:00 pmRNSInterim Results 2009
22nd Jul 20094:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20094:35 pmRNSPrice Monitoring Extension
26th May 200911:08 amRNSHolding(s) in Company
1st May 20099:30 amRNSDirectorate Change
1st May 20099:28 amRNSResult of AGM
1st May 20097:00 amRNSDIRECTORATE CHANGE
14th Apr 20091:45 pmRNSInterim Management Statement
6th Apr 20095:30 pmRNSPRELIMINARY RESULTS
23rd Jan 200912:27 pmRNSAnnual Information Update
19th Nov 200811:04 amRNSInterim Management Statement
12th Sep 20082:09 pmRNSFurther Update on Xian Haotian
29th Aug 20084:00 pmRNSInterim Results
30th May 20083:18 pmRNSResult of AGM and SGM
19th May 20087:30 amRNSInterim Management Statement
29th Apr 20082:47 pmRNSFinal Results
29th Apr 20088:39 amRNSXian Haotian Circular
28th Apr 20082:09 pmRNSCirc re Xian Haotian

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.